ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,770.20
0.55%
US Tech 100
19,636.04
0.55%
다우존스 지수
42,801.72
0.52%
Bitcoin
82,200.32
2.00%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Merus NV (MRUS) 시세

Merus NV

Merus NV (MRUS)

NASDAQ
46.07
-0.03
(-0.07%)
마감 10 3월 5:00AM
15분 지연
46.20
0.13
(0.28%)
시간외 거래: 7:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
46.20
매수가
43.65
매도가
84.00
거래량
646,746
45.3172 일간 변동폭 47.21
37.77 52주 범위 61.61
market_cap
3.192B
전일 종가
46.10
개장가
45.82
최근 거래 시간
200
@
46.2
(formt)
마지막 거래 시간
재정 규모
US$ 29,868,736
VWAP
46.1831
평균 볼륨(3m)
627,763
발행 주식
69,090,469
배당수익률
-
주가수익률
0.00
주당순이익(EPS)
-
매출
43.95M
순이익
-154.94M

Merus NV 정보

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative ... Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others. 더 보기

섹터
Gen Med & Surgical Hospitals
산업
Gen Med & Surgical Hospitals
웹사이트
www.merus.nl
본부
Utrecht, Utrecht, Nld
설립됨
-
Merus NV is listed in the Gen Med & Surgical Hospitals sector of the 나스닥 with ticker MRUS. The last closing price for Merus NV was US$46.10. Over the last year, Merus NV shares have traded in a share price range of US$ 37.77 to US$ 61.61.

Merus NV currently has 69,090,469 shares in issue. The market capitalisation of Merus NV is US$3.19 billion.

MRUS 최신 뉴스

추가 뉴스

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
28 2월 2025
MRUS (-0.07%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
22 2월 2025
MRUS (-0.07%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 2월 2025
MRUS (-0.07%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
01 2월 2025
MRUS (-0.07%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
01 2월 2025
MRUS (-0.07%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.9552.1107304674545.24547.6743.5877808445.82518009CS
44.189.9476439790642.0248.09539.7865584444.76937125CS
124.8911.837327523641.3148.09537.7762776342.75052941CS
26-3.95-7.8763708873450.1555.3937.7757492245.81093668CS
52-2.15-4.4467425025948.3561.6137.7768207949.01906203CS
15620.0376.538020634326.1761.6112.0345972336.34254423CS
26029.53177.14457108616.6761.6110.1835611133.2074656CS

MRUS - Frequently Asked Questions (FAQ)

What is the current Merus NV share price?
The current share price of Merus NV is US$ 46.20
How many Merus NV shares are in issue?
Merus NV has 69,090,469 shares in issue
What is the market cap of Merus NV?
The market capitalisation of Merus NV is USD 3.19B
What is the 1 year trading range for Merus NV share price?
Merus NV has traded in the range of US$ 37.77 to US$ 61.61 during the past year
What is the reporting currency for Merus NV?
Merus NV reports financial results in USD
What is the latest annual turnover for Merus NV?
The latest annual turnover of Merus NV is USD 43.95M
What is the latest annual profit for Merus NV?
The latest annual profit of Merus NV is USD -154.94M
What is the registered address of Merus NV?
The registered address for Merus NV is UPPSALALAAN 17, UTRECHT, UTRECHT, 3584 CT
What is the Merus NV website address?
The website address for Merus NV is www.merus.nl
Which industry sector does Merus NV operate in?
Merus NV operates in the GEN MED & SURGICAL HOSPITALS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
570.43k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.54M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.13M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
332.1k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

MRUS Discussion

게시물 보기
Monksdream Monksdream 6 월 전
MRUS range bound
👍️0
Phosphene Phosphene 4 년 전
Merus and myTomorrows Announce Expansion of Collaboration for Screening and eNRGy Clinical Trial Awareness for Cancer Patients with Neuregulin 1 Fusion Tumors

https://www.globenewswire.com/news-release/2020/10/12/2107078/0/en/Merus-and-myTomorrows-Announce-Expansion-of-Collaboration-for-Screening-and-eNRGy-Clinical-Trial-Awareness-for-Cancer-Patients-with-Neuregulin-1-Fusion-Tumors.html
👍️0
Phosphene Phosphene 5 년 전
The Baker Brothers have 7% ownership.

https://whalewisdom.com/filer/baker-bros-advisors-llc#tabholdings_tab_link
👍️0
Phosphene Phosphene 5 년 전
Board Member: Victor Sandor

https://ir.merus.nl/board-member/victor-sandor

https://www.businesswire.com/news/home/20200824005127/en/Prelude-Therapeutics-Announces-Closing-50M-Series-Financing
👍️0
Phosphene Phosphene 5 년 전
Second Quarter 2020 Results:

https://www.globenewswire.com/news-release/2020/08/06/2074649/0/en/Merus-Announces-Financial-Results-for-the-Second-Quarter-and-Provides-Business-Update.html
👍️0
Phosphene Phosphene 5 년 전
https://merus.nl/
👍️0
Phosphene Phosphene 5 년 전
European cancer biotech Merus nabs Sanofi I-O chief Andrew Joe

https://www.fiercebiotech.com/biotech/european-cancer-biotech-merus-nabs-sanofi-i-o-chief-andrew-joe
👍️0

최근 히스토리

NASDAQ
MRUS
Merus NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지